December 18, 2017 10:56 AM ET


Company Overview of Remedy Pharmaceuticals, Inc.

Company Overview

Remedy Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of small molecule drugs for acute central nervous system disorders. It develops drugs for various disorders, including stroke, traumatic brain injury, spinal cord injury, organ ischemia, and CNS surgery. The company was founded in 2004 and is based in New York, New York.

122 West 27th Street

10th Floor

New York, NY 10001

United States

Founded in 2004



Key Executives for Remedy Pharmaceuticals, Inc.

Co-Founder and Chief Executive officer
Co-Founder and Executive Chairman
Chief Financial Officer
Age: 60
Vice President of Research & Development and General Counsel
Medical Director
Compensation as of Fiscal Year 2017.

Remedy Pharmaceuticals, Inc. Key Developments

David Epstein Joins Remedy Pharmaceuticals, Inc. as Special Advisor to Board of Directors

Remedy Pharmaceuticals announced that David Epstein has joined as special advisor to the Company’s board of directors. Until earlier 2016, Mr. Epstein spent two-and-a-half decades at Swiss-based Novartis, most recently as Division Head and CEO of the Pharmaceuticals business.

Remedy Pharmaceuticals Appoints Roger Ulrich to Board of Directors

Remedy Pharmaceuticals announced that Roger Ulrich has joined the company’s board of directors. Dr. Ulrich has many years of successful drug discovery and development experience. Prior to Acerta and Calistoga, Dr. Ulrich was senior scientific director with Merck Research Laboratories-Rosetta Inpharmatics.

Remedy Pharmaceuticals Receives FDA Fast Track Designation for CIRARA

Remedy Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational drug, CIRARA, for the treatment of Large Hemispheric Infarctions (LHI).

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Remedy Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at